TREA

98795718 - CELLSEEKER

Follow

Information

  • Trademark
  • 98795718
  • Serial Number
    98795718
  • Filing Date
    October 10, 2024
    a year ago
  • Transaction Date
    July 17, 2025
    6 months ago
  • Status Date
    April 03, 2025
    10 months ago
  • Location Date
    April 03, 2025
    10 months ago
  • Status Code
    641
  • Current Location
    TMO LAW OFFICE 128
    Employee Name
    XU, ELAINE
  • Attorney Docket Number
    T-5093 US
    Attorney Name
    Joi A. White
    Law Office Assigned Location Code
    O10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
CELLSEEKER
Case File Statements
  • GS0051: Pharmaceuticals; pharmaceutical preparations; pharmaceutical substances; therapeutics; therapeutic agents; biopharmaceuticals; medicines; drugs; vaccines; systems to express therapeutic proteins in vivo; gene therapy products; gene therapy preparations; in vivo nucleic acid, DNA, RNA, and mRNA technologies; lipid nanoparticles for medicinal use; binding moiety decorated lipid nanoparticles for medicinal use; lipid nanoparticles for durable cell reprogramming or cell engineering; binding moiety decorated lipid nanoparticles for durable cell reprogramming or cell engineering; cell engineering platforms; cell engineering platforms for treatment of human diseases, disorders and conditions; technology platforms for developing and engineering therapeutic cells; in vivo cell engineering platforms; transient in vivo cell engineering platforms for durable gene therapy; technology platforms for transfection, namely, binding moiety decorated lipid nanoparticles for genetic engineering; reagents for transfection; reagents for transfection in vivo; reagents for transfection, namely, binding moiety decorated lipid nanoparticles; technology platforms for delivery of a payload by binding moiety decorated lipid nanoparticles including antibody decorated lipid nanoparticles; technology platforms for delivery of a nucleic acid payload; technology platforms for delivery of a negatively charged payload; biologics delivery systems; biologics delivery platforms; reagents for delivery of a payload by binding moiety decorated lipid nanoparticles including antibody decorated lipid nanoparticles; cell engineering platforms consisting of reagents, lipid nanoparticles, cell receptors, proteins, recombinant protein binders, mRNA, and antibodies or antigen binding portions thereof; biological technology platforms consisting of reagents, lipid nanoparticles, cell receptors, proteins, recombinant protein binders, nucleic acid, DNA, RNA, mRNA, and antibodies or antigen binding portions thereof, for the treatment and prevention of treatment of human diseases, disorders and conditions; chemical reagents for medical uses; clinical medical reagents; reagents for medical use; biological reagents for medical use; binding moiety decorated lipid nanoparticles;
Case File Event Statements
  • 10/11/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/11/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/21/2025 - 10 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/3/2025 - 10 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/3/2025 - 10 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/30/2025 - 7 months ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 4/3/2025 - 10 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/30/2025 - 7 months ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR